VIZIMPRO FILM-COATED TABLET 30MG

Product Information

Registration Status: Active

VIZIMPRO FILM-COATED TABLET 30MG is approved to be sold in Singapore with effective from 2020-06-25. It is marketed by PFIZER PTE LTD, with the registration number of SIN15967P.

This product contains Dacomitinib 30 mg in the form of TABLET, FILM COATED. It is approved for ORAL use.

This product is manufactured by Pfizer Manufacturing Deutschland GmbH in GERMANY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Dacomitinib

Description

Dacomitinib has been investigated for the treatment of Lung Cancer.

Active Ingredient/Synonyms

Dacomitinib anhydrous | Dacomitinib |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank